title: Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome.
authors.affiliation: Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2 Yuh Der Road, Taichung, 404, Taiwan. windsun@gmail.com.
authors.forename: Che-Hung
authors.initials: CH
authors.lastname: Lin
authors.affiliation: Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2 Yuh Der Road, Taichung, 404, Taiwan.|Stem Cell Research Lab., Department of Medical Research, China Medical University Hospital, 2 Yuh Der Road, Taichung, 404, Taiwan.|China Medical University, 2 Yuh Der Road, Taichung, 404, Taiwan.
authors.forename: Su-Peng
authors.initials: SP
authors.lastname: Yeh
authors.affiliation: Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2 Yuh Der Road, Taichung, 404, Taiwan.
authors.forename: Tze-Yi
authors.initials: TY
authors.lastname: Lin
mesh_terms: D001374:Azacitidine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D016463:Sweet Syndrome / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D001374:Azacitidine